X-Ray Fluorescence (XRF) Instrument Irvine Medical Products Laboratory (IRVLMP)

SOL #: OC-2026-133864Sources Sought

Overview

Buyer

Health And Human Services
Food And Drug Administration
FDA OFFICE OF ACQ GRANT SVCS
Rockville, MD, 20852, United States

Place of Performance

Silver Spring, MD

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

Chemical Analysis Instruments (6630)

Set Aside

No set aside specified

Timeline

1
Posted
May 15, 2026
2
Response Deadline
May 21, 2026, 6:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The U.S. Food and Drug Administration (FDA), specifically the Irvine Medical Products Laboratory (IRVLMP), is conducting market research through a Sources Sought / Request for Information (RFI) to identify potential sources for an X-Ray Fluorescence (XRF) Instrument. This instrument is required for elemental analysis of regulated commodities, focusing on the rapid, non-destructive detection of toxic heavy metals. Responses are due Thursday, May 21, 2026, at 2:00 PM Eastern Time.

Requirement Details

The FDA requires one (1) benchtop XRF Instrument with specific salient characteristics:

  • Optics: Doubly Curved Crystal (DCC) x-ray optics with monochromatic excitation.
  • Detection Limits: Limit of Detection (LOD) for elemental lead ≤ 0.03 ppm; LOD for elemental mercury ≤ 0.05 ppm.
  • Sample Range: Sample mass range from 0.05 grams to 3.0 grams.
  • Calibration: Calibration range from LOD up to ≥ 10,000 ppm.
  • Configuration: Benchtop or portable, with a maximum footprint of 30" W × 30" D × 30" H.
  • Power: 110–120V.

Contract & Timeline

  • Type: Sources Sought / Market Research (not a solicitation)
  • Set-Aside: None specified
  • Response Due: May 21, 2026, 2:00 PM ET
  • Published: May 15, 2026
  • Place of Performance: Silver Spring, MD

Requested Information from Vendors

Interested vendors should provide:

  • Company contact information, business size, and socioeconomic status.
  • Applicable NAICS codes and associated business size.
  • Manufacturer, product name, and model number of the proposed instrument.
  • Detailed specifications demonstrating compliance with all salient characteristics.
  • Country of manufacture.
  • GSA Federal Supply Schedule (FSS) contract number, if applicable.
  • Estimated delivery time and price range (for planning purposes).

Response Instructions

  • Submission: Electronically via email to freshta.javid@fda.hhs.gov.
  • Subject Line: "Sources Sought/RFI – OC-2026-133864 – XRF Instrument".
  • Page Limit: Maximum ten (10) pages.
  • Note: No debriefs or feedback will be provided. This RFI is for market research only and does not guarantee a future solicitation or commitment to award. The government will not pay for response costs.

People

Points of Contact

Freshta JavidPRIMARY
freshta.javid@fda.hhs.gov
13017960385

Files

Files

Download

Versions

Version 1Viewing
Sources Sought
Posted: May 15, 2026
X-Ray Fluorescence (XRF) Instrument Irvine Medical Products Laboratory (IRVLMP) | GovScope